Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayo Yamada

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Nature Cell Biology|February 19, 2022
Author Correction: Cell fate decisions are specified by the dynamic ERK interactomeAlex von Kriegsheim, Daniela Baiocchi, Marc Birtwistle, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 6, 2013
Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus-associated T or natural killer cell lymphoproliferative diseasesAkihisa Sawada, Masami Inoue, Maho Koyama-Sato, et al.
Pediatric Blood & Cancer|October 16, 2015
Feasibility of Cancer Immunotherapy with WT1 Peptide Vaccination for Solid and Hematological Malignancies in ChildrenAkihisa Sawada, Masami Inoue, Osamu Kondo, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Nature Cell Biology|February 19, 2022
Author Correction: Cell fate decisions are specified by the dynamic ERK interactomeAlex von Kriegsheim, Daniela Baiocchi, Marc Birtwistle, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 6, 2013
Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus-associated T or natural killer cell lymphoproliferative diseasesAkihisa Sawada, Masami Inoue, Maho Koyama-Sato, et al.
Pediatric Blood & Cancer|October 16, 2015
Feasibility of Cancer Immunotherapy with WT1 Peptide Vaccination for Solid and Hematological Malignancies in ChildrenAkihisa Sawada, Masami Inoue, Osamu Kondo, et al.
Pageof 3